Denenberg, the chief of pediatrics with Corewell, says the Neonatal Intensive Care Unit is nearly at capacity as well.
Before the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a ...
GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
The new CDC numbers on flu season will come out early next week. There was a delay because of federal offices being closed on ...
A prospective cohort study conducted across five European countries found that respiratory syncytial virus (RSV) infection in ...